Cardiac Marker Point-Of-Care Testing in the Emergency Department and Cardiac Care Unit (Beckman Conference) Cardiac Marker Point-Of-Care Testing in the Emergency Department and Cardiac Care Unit (Beckman Conference)

Cardiac Marker Point-Of-Care Testing in the Emergency Department and Cardiac Care Unit (Beckman Conference‪)‬

Clinical Chemistry 1998, August, 44, 8

    • $5.99
    • $5.99

Publisher Description

Four million chest pain patients are admitted each year for ruling out acute myocardial infarction (AMI). [1] Up to 70% of patients are admitted to the Cardiac Care Unit (CCU) for suspected AMI rule out (1), with estimates suggesting that two to three billion dollars per year could be saved caring for this population in a less intensive setting (2). However, AMI patients may present to the Emergency Department (ED) with normal or nondiagnostic electrocardiograms (ECGs) 50% of the time, making early diagnosis of AMI difficult (3). Up to 8% of AMI patients may be inadvertently discharged from the ED, and this subset of patients accounts for 20% of emergency medical malpractice dollar losses and leads to increased morbidity and mortality. (4, 5). Frequent misdiagnoses given to AMI patients inadvertently discharged from the ED include esophagitis, muscle strain, and exacerbation of chronic obstructive pulmonary disease. In a recent review of missed AMI closed malpractice claims, ~25% of missed AMI cases were because of ECG misinterpretation, in 25% of cases the ECG was correctly interpreted but the clinical importance of the ECG findings were not appreciated, and the remaining 50% had nondiagnostic ECGs and atypical symptom complexes (6).

GENRE
Science & Nature
RELEASED
1998
August 1
LANGUAGE
EN
English
LENGTH
16
Pages
PUBLISHER
American Association for Clinical Chemistry, Inc.
SELLER
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
SIZE
189.5
KB
Reporting of Cardiac Troponin Concentrations (Letters) (Letter to the Editor) Reporting of Cardiac Troponin Concentrations (Letters) (Letter to the Editor)
2002
Impact of CK-MB Testing Policies on Hospital Length of Stay and Laboratory Costs for Patients with Myocardial Infarction Or Chest Pain (Test Utilization and Outcomes) Impact of CK-MB Testing Policies on Hospital Length of Stay and Laboratory Costs for Patients with Myocardial Infarction Or Chest Pain (Test Utilization and Outcomes)
1997
Increased Concentrations of Cardiac Troponin I are Equivalent to Increased Cardiac Troponin T in Identifying Chest Pain Patients at Short-Term Risk of Myocardial Infarction (Letters) Increased Concentrations of Cardiac Troponin I are Equivalent to Increased Cardiac Troponin T in Identifying Chest Pain Patients at Short-Term Risk of Myocardial Infarction (Letters)
1998
Role of Biomarkers in Risk Stratification of Acute Coronary Syndrome (Report) Role of Biomarkers in Risk Stratification of Acute Coronary Syndrome (Report)
2010
Peripartum Cardiomyopathy Peripartum Cardiomyopathy
2021
Pattern Recognition Techniques Applied to Biomedical Problems Pattern Recognition Techniques Applied to Biomedical Problems
2020
Doping in Sport: Misuse, Analytical Tests, And Legal Aspects (Editorial) Doping in Sport: Misuse, Analytical Tests, And Legal Aspects (Editorial)
1997
Vitamin E and Coronary Heart Disease in Tunisians (Nutrition) (Clinical Report) Vitamin E and Coronary Heart Disease in Tunisians (Nutrition) (Clinical Report)
2000
Endothelial Nitric Oxide Synthase Haplotypes Are Associated with Features of Metabolic Syndrome (Endocrinology and Metabolism) (Survey) Endothelial Nitric Oxide Synthase Haplotypes Are Associated with Features of Metabolic Syndrome (Endocrinology and Metabolism) (Survey)
2007
Alanine Aminotransferase As an Independent Predictor of Incident Nonalcoholic Fatty Liver Disease (Letters) (Letter to the Editor) Alanine Aminotransferase As an Independent Predictor of Incident Nonalcoholic Fatty Liver Disease (Letters) (Letter to the Editor)
2007
T-Cell Regulatory Gene CTLA-4 Polymorphism/Haplotype Association with Autoimmune Pancreatitis (Clinical Immunology) T-Cell Regulatory Gene CTLA-4 Polymorphism/Haplotype Association with Autoimmune Pancreatitis (Clinical Immunology)
2007
Percent Free Prostate-Specific Antigen in Assessing the Probability of Prostate Cancer Under Optimal Analytical Conditions (Enzymes and Protein Markers) Percent Free Prostate-Specific Antigen in Assessing the Probability of Prostate Cancer Under Optimal Analytical Conditions (Enzymes and Protein Markers)
1998